Company News

Industry Benchmark: HKIG BIOSCIENCES Co-authors the pTau217 Group Standard, Advancing Standardisation of AD Blood Testing

The Chinese Society of Inspection and Quarantine has officially approved and issued the group standard “Guidelines for Analytical and Diagnostic Performance of the Alzheimer’s Disease Plasma Biomarker pTau217”, filling a gap in the domestic specification for p-Tau217 testing. As a contributing enterprise, HKIG BIOSCIENCES will continue to advance the standardisation and local implementation of AD blood testing.

Public Consultation Open on the Draft Group Standard for Analytical Performance of Plasma pTau217 in Alzheimer’s Disease

HKIG BIOSCIENCES (Hangzhou) responded promptly to the public consultation on the draft group standard “Analytical Performance Requirements for the Plasma Biomarker pTau217 in Alzheimer’s Disease”.

HKIG Immune Technology Supports the Establishment of the AD Biomarker Testing Standards Drafting Group

Led by the Medical Standards Working Group and the Medical Testing Branch of the Chinese Society of Inspection and Quarantine, a drafting group for the Alzheimer’s disease (AD) biomarker testing standard series has been established.

2025 Annual Academic Conference of the Zhejiang Society of Biochemistry and Molecular Biology Successfully Held

HKIG Immune Technology Co-hosts the 2nd ADX Symposium on Plasma AD Biomarker Testing and Standardisation

From 5 to 6 July, the 2nd Symposium on Plasma Biomarker Testing and Standardisation for Alzheimer’s Disease (ADX 2025), co-hosted by HKIG Immune Technology, was held and concluded successfully.